RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jazz Pharmaceuticals Stock

Jazz Pharmaceuticals ROE 2024

Jazz Pharmaceuticals ROE

0.11

Ticker

JAZZ

ISIN

IE00B4Q5ZN47

WKN

A1JS1K

In 2024, Jazz Pharmaceuticals's return on equity (ROE) was 0.11, a -252.86% increase from the -0.07 ROE in the previous year.

Jazz Pharmaceuticals Aktienanalyse

What does Jazz Pharmaceuticals do?

Jazz Pharmaceuticals PLC is a global biopharmaceutical company specializing in treating life-threatening diseases. The company was founded in 2003 in Ireland and now operates in Europe, North America, and other parts of the world. Jazz's business model focuses on offering innovative therapies for diseases that have no cure or unsatisfactory existing treatments. The company has a well-planned pipeline of high-quality products, supported by excellent customer service and innovative marketing strategies. Jazz holds numerous patents for various medications that can be used for different medical purposes. The company offers four different medical specialties: hematology-oncology, narcolepsy, pain medicine, and psychiatric disorders. Its most well-known specialty is hematology-oncology, where Jazz concentrates on developing therapies for hematological cancers such as leukemia, lymphomas, and myeloma. Furthermore, Jazz provides medications for rare diseases such as Gaucher's disease and Fabry disease. In the field of pain medicine, Jazz Pharmaceuticals has developed specific therapies for patients with sleep disorders and pain. The company also offers treatments for depressive disorders and obsessive-compulsive disorders. Another important area for Jazz is the development of medications for patients suffering from narcolepsy, a condition that causes constant fatigue and sudden sleep attacks, significantly impacting daily life for many patients. One of Jazz Pharmaceuticals' most well-known products is Xyrem, which is used to treat narcolepsy. Xyrem is a potent sedative with a high potential for addiction and can only be prescribed by qualified doctors. Another key product from Jazz is Vyxeos, a medication for the treatment of acute myeloid leukemia, an aggressive form of blood cancer typically difficult to treat. Vyxeos is a dual-action medication that can significantly improve the survival chances of leukemia patients. Jazz Pharmaceuticals is a global leader in hematology-oncology and has become a significant player in the market for medical therapies in recent years. The company currently employs over 1,500 employees and is listed on the NASDAQ. Its headquarters are located in Dublin, Ireland. Jazz Pharmaceuticals is dedicated to supporting patients worldwide with high-quality medical products and services. Jazz Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Jazz Pharmaceuticals's Return on Equity (ROE)

Jazz Pharmaceuticals's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Jazz Pharmaceuticals's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Jazz Pharmaceuticals's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Jazz Pharmaceuticals’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Jazz Pharmaceuticals stock

What is the ROE (Return on Equity) of Jazz Pharmaceuticals this year?

The ROE of Jazz Pharmaceuticals this year is 0.11 undefined.

How has the Return on Equity (ROE) of Jazz Pharmaceuticals developed compared to the previous year?

The ROE of Jazz Pharmaceuticals has increased by -252.86% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Jazz Pharmaceuticals?

A high ROE indicates that Jazz Pharmaceuticals generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Jazz Pharmaceuticals?

A low ROE can indicate that Jazz Pharmaceuticals is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Jazz Pharmaceuticals affect the company?

A change in ROE (Return on Equity) of Jazz Pharmaceuticals can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Jazz Pharmaceuticals?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Jazz Pharmaceuticals?

Some factors that can influence Jazz Pharmaceuticals's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Jazz Pharmaceuticals pay?

Over the past 12 months, Jazz Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jazz Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Jazz Pharmaceuticals?

The current dividend yield of Jazz Pharmaceuticals is .

When does Jazz Pharmaceuticals pay dividends?

Jazz Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Jazz Pharmaceuticals?

Jazz Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Jazz Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Jazz Pharmaceuticals located?

Jazz Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jazz Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jazz Pharmaceuticals from 9/28/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/28/2024.

When did Jazz Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/28/2024.

What was the dividend of Jazz Pharmaceuticals in the year 2023?

In the year 2023, Jazz Pharmaceuticals distributed 0 USD as dividends.

In which currency does Jazz Pharmaceuticals pay out the dividend?

The dividends of Jazz Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jazz Pharmaceuticals

Our stock analysis for Jazz Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jazz Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.